Tirzepatide Injectable Peptide Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP 1 or glucagon receptors Nature Communications Recent advances in peptide based therapies for obesity and type 2 diabetes ScienceDirect When do we choose semaglotide and when does terzipatide? EASO has just announced that it will update its algorithm with evidence until November 2025 Warning: It depends on the clinical goal.